ATF3 is a key regulator of macrophage IFN responses

Journal of Immunology

Volumn 195, Issue 9, 2015, Pages 4446-4455

  Labzin, Larisa I ^a   Schmidt, Susanne V ^b   Masters, Seth L ^c,d   Beyer, Marc ^b   Krebs, Wolfgang ^b   Klee, Kathrin ^b   Stahl, Rainer ^a   Lütjohann, Dieter ^a   Schultze, Joachim L ^b   Latz, Eicke ^a,e,f   De Nardo, Dominic ^a,c,d  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; BETA INTERFERON; INTERFERON; PATTERN RECOGNITION RECEPTOR; ALPHA BETA INTERFERON RECEPTOR; PROTEIN BINDING; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; BETA INTERFERON GENE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRAL CLEARANCE; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DENDRITIC CELL; DNA MICROARRAY; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; IMMUNOBLOTTING; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MONOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; INTERFERON-BETA; MACROPHAGES; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTOR, INTERFERON ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84945157580     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500204     Document Type: Article

References (64)

1. Medzhitov, R., and T. Horng. 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9: 692-703.
2. Cavlar, T., A. Ablasser, and V. Hornung. 2012. Induction of type I IFNs by intracellular DNA-sensing pathways. Immunol. Cell Biol. 90: 474-482.
3. Ivashkiv, L. B., and L. T. Donlin. 2014. Regulation of type I interferon responses. Nat. Rev. Immunol. 14: 36-49.
4. Theofilopoulos, A. N., R. Baccala, B. Beutler, and D. H. Kono. 2005. Type I interferons (α/β) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.
5. Schoggins, J. W. 2014. Interferon-stimulated genes: roles in viral pathogenesis. Curr. Opin. Virol. 6: 40-46.
6. Sadler, A. J., and B. R. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8: 559-568.
7. Schoggins, J. W., M. Dorner, M. Feulner, N. Imanaka, M. Y. Murphy, A. Ploss, and C. M. Rice. 2012. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc. Natl. Acad. Sci. USA 109: 14610-14615.
8. Liu, S. Y., D. J. Sanchez, R. Aliyari, S. Lu, and G. Cheng. 2012. Systematic identification of type I and type II interferon-induced antiviral factors. Proc. Natl. Acad. Sci. USA 109: 4239-4244.
9. Schoggins, J. W., S. J. Wilson, M. Panis, M. Y. Murphy, C. T. Jones, P. Bieniasz, and C. M. Rice. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485.
10. Zhang, Y., C. W. Burke, K. D. Ryman, and W. B. Klimstra. 2007. Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 81: 11246-11255.
11. Müller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
12. Hwang, S. Y., P. J. Hertzog, K. A. Holland, S. H. Sumarsono, M. J. Tymms, J. A. Hamilton, G. Whitty, I. Bertoncello, and I. Kola. 1995. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. USA 92: 11284-11288.
13. Sancho-Shimizu, V., R. Perez de Diego, E. Jouanguy, S. Y. Zhang, and J. L. Casanova. 2011. Inborn errors of anti-viral interferon immunity in humans. Curr. Opin. Virol. 1: 487-496.
14. Banchereau, J., and V. Pascual. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392.
15. Kondo, T., T. Kawai, and S. Akira. 2012. Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 33: 449-458.
16. Gilchrist, M., V. Thorsson, B. Li, A. G. Rust, M. Korb, J. C. Roach, K. Kennedy, T. Hai, H. Bolouri, and A. Aderem. 2006. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441: 173-178.
17. De Nardo, D. 2015. Toll-like receptors: activation, signalling and transcriptional modulation. Cytokine 74: 181-189.
18. Whitmore, M. M., A. Iparraguirre, L. Kubelka, W. Weninger, T. Hai, and B. R. Williams. 2007. Negative regulation of TLR-signaling pathways by activating transcription factor-3. J. Immunol. 179: 3622-3630.
19. Khuu, C. H., R. M. Barrozo, T. Hai, and S. L. Weinstein. 2007. Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages. Mol. Immunol. 44: 1598-1605.
20. Rosenberger, C. M., A. E. Clark, P. M. Treuting, C. D. Johnson, and A. Aderem. 2008. ATF3 regulates MCMV infection in mice by modulating IFN-γ expression in natural killer cells. Proc. Natl. Acad. Sci. USA 105: 2544-2549.
21. Cai, X., Y. Xu, Y. M. Kim, J. Loureiro, and Q. Huang. 2014. PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3. J. Immunol. 192: 3383-3389.
22. Goldeck, M., M. Schlee, G. Hartmann, and V. Hornung. 2014. Enzymatic synthesis and purification of a defined RIG-I ligand. Methods Mol. Biol. 1169: 15-25.
23. Hornung, V., F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. Fitzgerald, and E. Latz. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9: 847-856.
24. Stutz, A., G. L. Horvath, B. G. Monks, and E. Latz. 2013. ASC speck formation as a readout for inflammasome activation. Methods Mol. Biol. 1040: 91-101.
25. Roberts, Z. J., N. Goutagny, P. Y. Perera, H. Kato, H. Kumar, T. Kawai, S. Akira, R. Savan, D. van Echo, K. A. Fitzgerald, et al. 2007. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J. Exp. Med. 204: 1559-1569.
26. De Nardo, D., L. I. Labzin, H. Kono, R. Seki, S. V. Schmidt, M. Beyer, D. Xu, S. Zimmer, C. Lahrmann, F. A. Schildberg, et al. 2014. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat. Immunol. 15: 152-160.
27. Xue, J., S. V. Schmidt, J. Sander, A. Draffehn, W. Krebs, I. Quester, D. De Nardo, T. D. Gohel, M. Emde, L. Schmidleithner, et al. 2014. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40: 274-288.
28. Rusinova, I., S. Forster, S. Yu, A. Kannan, M. Masse, H. Cumming, R. Chapman, and P. J. Hertzog. 2013. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41: D1040-D1046.
29. Berger Rentsch, M., and G. Zimmer. 2011. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS One 6: e25858.
30. Garber, M., N. Yosef, A. Goren, R. Raychowdhury, A. Thielke, M. Guttman, J. Robinson, B. Minie, N. Chevrier, Z. Itzhaki, et al. 2012. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 47: 810-822.
31. Krebs, W., S. V. Schmidt, A. Goren, D. De Nardo, L. Labzin, A. Bovier, T. Ulas, H. Theis, M. Kraut, E. Latz, et al. 2014. Optimization of transcription factor binding map accuracy utilizing knockout-mouse models. Nucleic Acids Res. 42: 13051-13060.
32. Ostuni, R., V. Piccolo, I. Barozzi, S. Polletti, A. Termanini, S. Bonifacio, A. Curina, E. Prosperini, S. Ghisletti, and G. Natoli. 2013. Latent enhancers activated by stimulation in differentiated cells. Cell 152: 157-171.
33. Lavin, Y., D. Winter, R. Blecher-Gonen, E. David, H. Keren-Shaul, M. Merad, S. Jung, and I. Amit. 2014. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159: 1312-1326.
34. Honda, K., A. Takaoka, and T. Taniguchi. 2006. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360.
35. Tanaka, Y., and Z. J. Chen. 2012. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5: ra20.
36. Barozzi, I., M. Simonatto, S. Bonifacio, L. Yang, R. Rohs, S. Ghisletti, and G. Natoli. 2014. Coregulation of transcription factor binding and nucleosome occupancy through DNA features of mammalian enhancers. Mol. Cell 54: 844-857.
37. Ghisletti, S., I. Barozzi, F. Mietton, S. Polletti, F. De Santa, E. Venturini, L. Gregory, L. Lonie, A. Chew, C. L. Wei, et al. 2010. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32: 317-328.
38. Heinz, S., C. Benner, N. Spann, E. Bertolino, Y. C. Lin, P. Laslo, J. X. Cheng, C. Murre, H. Singh, and C. K. Glass. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38: 576-589.
39. Mancino, A., A. Termanini, I. Barozzi, S. Ghisletti, R. Ostuni, E. Prosperini, K. Ozato, and G. Natoli. 2015. A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages. Genes Dev. 29: 394-408.
40. Panne, D., T. Maniatis, and S. C. Harrison. 2007. An atomic model of the interferon-β enhanceosome. Cell 129: 1111-1123.
41. Hai, T., C. C. Wolford, and Y. S. Chang. 2010. ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component? Gene Expr. 15: 1-11.
42. Taylor, M. W., W. M. Grosse, J. E. Schaley, C. Sanda, X. Wu, S. C. Chien, F. Smith, T. G. Wu, M. Stephens, M. W. Ferris, et al. 2004. Global effect of PEG-IFN-α and ribavirin on gene expression in PBMC in vitro. J. Interferon Cytokine Res. 24: 107-118.
43. Hunt, D., G. Raivich, and P. N. Anderson. 2012. Activating transcription factor 3 and the nervous system. Front. Mol. Neurosci. 5: 7.
44. Liu, S. Y., R. Aliyari, K. Chikere, G. Li, M. D. Marsden, J. K. Smith, O. Pernet, H. Guo, R. Nusbaum, J. A. Zack, et al. 2013. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 38: 92-105.
45. Blanc, M., W. Y. Hsieh, K. A. Robertson, K. A. Kropp, T. Forster, G. Shui, P. Lacaze, S. Watterson, S. J. Griffiths, N. J. Spann, et al. 2013. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 38: 106-118.
46. Park, K., and A. L. Scott. 2010. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J. Leukoc. Biol. 88: 1081-1087.
47. Gold, E. S., S. A. Ramsey, M. J. Sartain, J. Selinummi, I. Podolsky, D. J. Rodriguez, R. L. Moritz, and A. Aderem. 2012. ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation. J. Exp. Med. 209: 807-817.
48. Abt, M. C., L. C. Osborne, L. A. Monticelli, T. A. Doering, T. Alenghat, G. F. Sonnenberg, M. A. Paley, M. Antenus, K. L. Williams, J. Erikson, et al. 2012. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37: 158-170.
49. Kawashima, T., A. Kosaka, H. Yan, Z. Guo, R. Uchiyama, R. Fukui, D. Kaneko, Y. Kumagai, D. J. You, J. Carreras, et al. 2013. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β. Immunity 38: 1187-1197.
50. Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8: 533-544.
51. Moore, R. N., H. S. Larsen, D. W. Horohov, and B. T. Rouse. 1984. Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. Science 223: 178-181.
52. Hasan, M., J. Koch, D. Rakheja, A. K. Pattnaik, J. Brugarolas, I. Dozmorov, B. Levine, E. K. Wakeland, M. A. Lee-Kirsch, and N. Yan. 2013. Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes. Nat. Immunol. 14: 61-71.
53. Rehwinkel, J., J. Maelfait, A. Bridgeman, R. Rigby, B. Hayward, R. A. Liberatore, P. D. Bieniasz, G. J. Towers, L. F. Moita, Y. J. Crow, et al. 2013. SAMHD1-dependent retroviral control and escape in mice. EMBO J. 32: 2454-2462.
54. Behrendt, R., T. Schumann, A. Gerbaulet, L. A. Nguyen, N. Schubert, D. Alexopoulou, U. Berka, S. Lienenklaus, K. Peschke, K. Gibbert, et al. 2013. Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response. Cell Reports 4: 689-696.
55. Litvak, V., A. V. Ratushny, A. E. Lampano, F. Schmitz, A. C. Huang, A. Raman, A. G. Rust, A. Bergthaler, J. D. Aitchison, and A. Aderem. 2012. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature 490: 421-425.
56. Smale, S. T. 2010. Selective transcription in response to an inflammatory stimulus. Cell 140: 833-844.
57. Nusinzon, I., and C. M. Horvath. 2006. Positive and negative regulation of the innate antiviral response and β interferon gene expression by deacetylation. Mol. Cell. Biol. 26: 3106-3113.
58. Hertzog, P. J., and B. R. Williams. 2013. Fine tuning type I interferon responses. Cytokine Growth Factor Rev. 24: 217-225.
59. L subunits of the type I interferon receptor. J. Biol. Chem. 271: 23630-23633.
60. Platanias, L. C., S. Uddin, and O. R. Colamonici. 1994. Tyrosine phosphorylation of the α and β subunits of the type I interferon receptor. Interferon-β selectively induces tyrosine phosphorylation of an α subunit-associated protein. J. Biol. Chem. 269: 17761-17764.
61. de Weerd, N. A., J. P. Vivian, T. K. Nguyen, N. E. Mangan, J. A. Gould, S. J. Braniff, L. Zaker-Tabrizi, K. Y. Fung, S. C. Forster, T. Beddoe, et al. 2013. Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1. Nat. Immunol. 14: 901-907.
62. Gold, E. S., A. H. Diercks, I. Podolsky, R. L. Podyminogin, P. S. Askovich, P. M. Treuting, and A. Aderem. 2014. 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling. Proc. Natl. Acad. Sci. USA 111: 10666-10671.
63. Reboldi, A., E. V. Dang, J. G. McDonald, G. Liang, D. W. Russell, and J. G. Cyster. 2014. Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345: 679-684.
64. Lee, P. Y., Y. Li, Y. Kumagai, Y. Xu, J. S. Weinstein, E. S. Kellner, D. C. Nacionales, E. J. Butfiloski, N. van Rooijen, S. Akira, et al. 2009. Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am. J. Pathol. 175: 2023-2033.